A carregar...
Polymer Micelle Formulations of Proteasome Inhibitor Carfilzomib for Improved Metabolic Stability and Anticancer Efficacy in Human Multiple Myeloma and Lung Cancer Cell Lines
Carfilzomib (CFZ) is a second-generation proteasome inhibitor drug approved for the treatment of multiple myeloma. Contrary to its excellent antimyeloma activity, CFZ has shown only limited efficacy in patients with solid malignancies. This lack of efficacy has been attributed in part to rapid degra...
Na minha lista:
| Publicado no: | J Pharmacol Exp Ther |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The American Society for Pharmacology and Experimental Therapeutics
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613964/ https://ncbi.nlm.nih.gov/pubmed/26311812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.115.226993 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|